Outcome of 490 Desensitizations to Chemotherapy Drugs with a Rapid One-Solution Protocol-Reference-Cited by-同舟云学术

Outcome of 490 Desensitizations to Chemotherapy Drugs with a Rapid One-Solution Protocol

Published:2018-09 Issue:5 Volume:6 Page:1621-1627.e6
ISSN:2213-2198
Container-title:The Journal of Allergy and Clinical Immunology: In Practice
language:en
Short-container-title:The Journal of Allergy and Clinical Immunology: In Practice

Author:

Pérez-Rodríguez Eva,Martínez-Tadeo Juan Antonio,Pérez-Rodríguez Natalia,Hernández-Santana Guacimara,Callero-Viera Ariel,Rodríguez-Plata Elena,García-Robaina José Carlos

Publisher

Elsevier BV

Subject

Immunology and Allergy

Reference16 articles.

1. Hypersensitivity to antineoplastic agents: mechanism and rapid desensitization;Castells;Cancer Immunol Immunother,2012

2. Hypersensitivity to chemotherapy: outcomes and safety of rapid desensitization in 413 cases;Castells;J Allergy Clin Immunol,2008

3. Hypersensitivity to antineoplastic agents: outcomes of 189 procedures with a new short protocol and novel diagnostic tools assessment;Madrigal-Burgaleta;Allergy,2013

4. A modified protocol for rapid desensitization to chemotherapy agents;Vidal;J Allergy Clin Immunol Pract,2016

5. Risk stratification and skin testing to guide re-exposure in taxane induced hypersensitivity reactions;Picard;J Allergy Clin Immunol,2015

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rapid Desensitization to Antitumoral Agents. Result from a Retrospective Study, DESARCh;Hospital Pharmacy;2024-09-05

2. Hypersensitivity Reactions to Taxanes: A Comprehensive and Systematic Review of the Efficacy and Safety of Desensitization;Clinical Reviews in Allergy & Immunology;2023-08-17

3. Immune Reactions in Major Types of Oncological Treatment;International Journal of Molecular Sciences;2023-07-09

4. Incidence and associated factors of cetuximab-induced hypersensitivity infusion reactions in 1392 cancer patients treated in four French areas: a possible association with Lyme disease?;BMC Cancer;2022-11-25

5. A pilot experience using a one-bag intravenous rapid desensitization protocol for chemotherapeutics and biologics in a cohort of patients with access to a delabeling pathway;Journal of Investigational Allergy and Clinical Immunology;2022-09-14